269 related articles for article (PubMed ID: 19221586)
1. Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.
Algar EM; Muscat A; Dagar V; Rickert C; Chow CW; Biegel JA; Ekert PG; Saffery R; Craig J; Johnstone RW; Ashley DM
PLoS One; 2009; 4(2):e4482. PubMed ID: 19221586
[TBL] [Abstract][Full Text] [Related]
2. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.
Gadd S; Sredni ST; Huang CC; Perlman EJ;
Lab Invest; 2010 May; 90(5):724-38. PubMed ID: 20212451
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors.
Wöhrle S; Weiss A; Ito M; Kauffmann A; Murakami M; Jagani Z; Thuery A; Bauer-Probst B; Reimann F; Stamm C; Pornon A; Romanet V; Guagnano V; Brümmendorf T; Sellers WR; Hofmann F; Roberts CW; Graus Porta D
PLoS One; 2013; 8(10):e77652. PubMed ID: 24204904
[TBL] [Abstract][Full Text] [Related]
4. SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?
Russo P; Biegel JA
Pediatr Blood Cancer; 2009 Mar; 52(3):312-3. PubMed ID: 19072985
[No Abstract] [Full Text] [Related]
5. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
[TBL] [Abstract][Full Text] [Related]
6. Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor.
Kerl K; Oyen F; Leuschner I; Schneppenheim R; Nagel I; Siebert R; Groll AH; Hartmann W; Barth PJ; Bartelheim K; Seringer A; Wardelmann E; Frühwald MC
Pediatr Blood Cancer; 2015 May; 62(5):897-900. PubMed ID: 25663425
[TBL] [Abstract][Full Text] [Related]
7. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
[TBL] [Abstract][Full Text] [Related]
8. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
[TBL] [Abstract][Full Text] [Related]
9. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
10. Biology and Treatment of Rhabdoid Tumor.
Geller JI; Roth JJ; Biegel JA
Crit Rev Oncog; 2015; 20(3-4):199-216. PubMed ID: 26349416
[TBL] [Abstract][Full Text] [Related]
11. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
Tsikitis M; Zhang Z; Edelman W; Zagzag D; Kalpana GV
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12129-34. PubMed ID: 16099835
[TBL] [Abstract][Full Text] [Related]
12. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract][Full Text] [Related]
13. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
[TBL] [Abstract][Full Text] [Related]
14. Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.
Hulsebos TJ; Kenter S; Verhagen WI; Baas F; Flucke U; Wesseling P
Acta Neuropathol; 2014 Sep; 128(3):439-48. PubMed ID: 24740647
[TBL] [Abstract][Full Text] [Related]
15. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
[TBL] [Abstract][Full Text] [Related]
16. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
[TBL] [Abstract][Full Text] [Related]
17. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.
Oruetxebarria I; Venturini F; Kekarainen T; Houweling A; Zuijderduijn LM; Mohd-Sarip A; Vries RG; Hoeben RC; Verrijzer CP
J Biol Chem; 2004 Jan; 279(5):3807-16. PubMed ID: 14604992
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.
Kim KH; Roberts CW
Cancer Genet; 2014 Sep; 207(9):365-72. PubMed ID: 24853101
[TBL] [Abstract][Full Text] [Related]
19. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.
Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L
Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation.
Han ZY; Richer W; Fréneaux P; Chauvin C; Lucchesi C; Guillemot D; Grison C; Lequin D; Pierron G; Masliah-Planchon J; Nicolas A; Ranchère-Vince D; Varlet P; Puget S; Janoueix-Lerosey I; Ayrault O; Surdez D; Delattre O; Bourdeaut F
Nat Commun; 2016 Jan; 7():10421. PubMed ID: 26818002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
